CRESTOR in Danish translation

• CRESTOR
• cresadex

Examples of using Crestor in English and their translations into Danish

take it at least 2 hours after taking Crestor.
magnesium i det, tage det mindst 2 timer efter indtagelse Cresadex.

has been observed in patients treated with Crestor.
hovedsagelig tubulær af oprindelse) hos patienter behandlet med Crestor.

in large amounts may increase the risk of liver problems with Crestor.
i store mængder kan øge risikoen for leverproblemer med Cresadex.

spironolactone because the risk of their side effects may be increased by Crestor.
makrolid Immunsuppressiva(fx tacrolimus) eller spironolacton, fordi risikoen for deres bivirkninger kan forhøjes med Cresadex.

may be performed while you use Crestor.
kan udføres, mens du bruger Cresadex.

Crestor 10 mg daily dose leads to a higher reduction in LDL-C compared with 5 mg.
At en dagsdosis af Crestor på 10 mg giver større reduktion i LDL- C end 5 mg.

OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF CRESTOR 5 mg see Annex I.
Samlet resume af den faglige vurdering af crestor 5 mg se bilag i.

Crestor with fibrates or niacin should be carefully weighed against the potential risks of such combinations.
Fordelen ved yderligere sænkning af lipidniveauerne ved kombineret brug af Crestor og fibrater eller niacin bør vægtes nøje mod den potentielle risiko ved disse kombinationer.

Studies to determine the effect of Crestor on the ability to drive and use machines have not been conducted.
Der er ikke foretaget undersøgelser af Crestor' s indflydelse på evnen til at føre bil eller betjene maskiner.

In a large study, 435 patients with heterozygous familial hypercholesterolaemia were given Crestor from 20 mg to 80 mg in a force-titration design.
I en stor undersøgelse af patienter med heterozygot familiær hyperkolesterolæmi fik 435 individer Crestor fra 20 mg til 80 mg i et force- titrerings design.

Before Treatment Crestor, as with other HMG-CoA reductase inhibitors,
Inden behandling Crestor bør, som andre HMG- CoA reduktasehæmmere,

In a force-titration, open label trial, 42 patients with homozygous familial hypercholesterolaemia were evaluated for their response to Crestor 20- 40 mg.
I et force- titrerings open label studie blev 42 patienter med homozygot familiær hyperkolesterolæmi evalueret for deres respons på 20- 40 mg Crestor.

Crestor should be discontinued
Crestor bør seponeres

Rosuvastatin(Crestor) 10 mg is currently authorised in the majority of MS as a start and maintenance dose with acceptable risk/ benefit ratio.
Rosuvastatin(Crestor) 10 mg er i øjeblikket godkendt i flertallet af medlemsstaterne som start- og vedligeholdelsesdosis med et acceptabelt risk/ benefit forhold.

During concomitant treatment with Crestor and cyclosporin, rosuvastatin AUC values were on average 7 times higher than those observed in healthy volunteers see Section 4.3 Contraindications.
Ved samtidig behandling med Crestor og ciclosporin var rosuvastatin' s AUC værdier i gennemsnit 7 gange højere end hos raske frivillige se afsnit 4. 3 Kontraindikationer.

Concomitant use of Crestor and gemfibrozil resulted in a 2-fold increase in rosuvastatin C max
Samtidig behandling med Crestor og gemfibrozil medførte en 2- foldig stigning i rosuvastatin' s Cmax og AUC se afsnit

morbidity studies with Crestor have not yet been completed.
morbiditets undersøgelser med Crestor endnu ikke er færdiggjort.

Liver Effects As with other HMG-CoA reductase inhibitors, Crestor should be used with caution in patients who consume excessive quantities of alcohol and/ or have a history of liver disease.
Leverpåvirkninger Som med andre HMG- CoA reduktasehæmmere bør Crestor anvendes med forsigtighed hos patienter som indtager store mængder alkohol og/ eller tidligere har haft leversygdom.

A Marketing Authorisation for Crestor(10 to 40 mg) was originally granted
Der blev oprindeligt udstedt en markedsføringstilladelse for Crestor(10 til 40 mg) til AstraZeneca i Nederlandene den 6. november 2002,

Clinical efficacy Crestor is effective in adults with hypercholesterolaemia,
Crestor er effektiv hos voksne med hyperkolesterolæmi med eller uden hypertriglyceridæmi uafhængig af race,